Calixar novel patent publication

CALIXAR announces the official grant of its patent by the European Patent Office for the synthesis of novel family of compounds for stabilizing native functional membrane proteins (EP 3 131 913 B1).

This patent issued from the extensive internal biochemistry research team is a great achievement in the development of CALIXAR know-how and IP.

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin

Contact us

Secure and boost your discovery programs.

Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ions Channels, Transporters, Receptors and Viral Proteins.

  • Conformational antibody development
  • Vaccine development
  • High-throughput ligand screening
  • Structure-based drug discovery
  • Immunoassays
  • Deorphanization projects
  • Identification of relevant targets
  • Expression of full-length membrane proteins
  • Functional isolation and stabilization of targets

© 2020 Calixar. All rights reserved.

Linkedin-in
Youtube